SYC also said that ALL of PTX's assets were winning.
That Cell Pryme M is ready now to go into the clinic with only a minor amendment to manufacturing details of their product needed by a 3rd party. Likely most keen first buyers would be CAR T developers who are right now only getting mediocre results with their product so far. Cell Pryme M doubles the % of helpful T cells, cells lasts longer (can last for decades) and find the tumour better. He also said that all patients who have received CAR-T over the past 10 years and are in complete/?cure or partial remission have one common factor: they all have a very high % of these Memory and Central Memory T cells.
Interestingly Cellpryme M also creates a significant increase in antiviral activity. Nothing planned on that yet.
PTX Media related, page-552
-
- There are more pages in this discussion • 1,062 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $34.62M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 31665 | 4.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.4¢ | 270379 | 4 |
View Market Depth
| Last trade - 07.09am 20/08/2024 (20 minute delay) ? |
| PTX (ASX) Chart |
Day chart unavailable